Narrative review demonstrates broad antitumor, antioxidant, and anti-inflammatory properties of curcumin, indicating substantial clinical therapeutic potential.
Curcumin belongs to a class of polyphenol compounds, and its source is the rhizome of turmeric (belonging to Zingiberaceae). This substance is the main component of turmeric releasing its own pharmacological activity. Pharmacological experiments have confirmed that It has anti-tumor, antioxidant and anti-inflammatory effects, accompanied by high efficiency and low toxicity. It also has high clinical promotion value. This paper reviews the pharmacological research progress of curcumin, hoping to provide new ideas for its clinical application and further research.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: